Life Science Investing NurExone Accepted into ARMI's BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing
Life Science Investing NurExone Demonstrates Reproducible, Dose-Dependent Vision Recovery in Preclinical Glaucoma Model
Life Science Investing NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana
Life Science Investing NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing
Life Science Investing NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
Life Science Investing NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment
